Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. (Q37967450)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2012

Language	Label	Description	Also known as
English	Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.	scientific article published on February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. (English)

1 reference

Europe PubMed Central

26 August 2017

type 2 diabetes

0 references

0 references

author name string

Toni Terry

1

1 reference

Europe PubMed Central

26 August 2017

Kalyani Raravikar

2

1 reference

Europe PubMed Central

26 August 2017

Nalurporn Chokrungvaranon

3

1 reference

Europe PubMed Central

26 August 2017

Peter D Reaven

4

1 reference

Europe PubMed Central

26 August 2017

publication date

1 February 2012

1 reference

Europe PubMed Central

26 August 2017

Current cardiology reports

1 reference

Europe PubMed Central

26 August 2017

14

1 reference

Europe PubMed Central

26 August 2017

1

1 reference

Europe PubMed Central

26 August 2017

79-88

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.1007/s11886-011-0238-6

0 references

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Hypothesis: the "metabolic memory", the new challenge of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Observation on renal outcomes in the Veterans Affairs Diabetes Trial

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0238-6

21 January 2018

Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160862

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11886-011-0238-6

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37967450&oldid=1434250630"